Viridian Therapeutics (VRDN)'s 30-day implied volatility (IV30) was 38.0% at the close on October 26, 2026, up from 36.7% the day before, against a 52-week range of 27.9% to 177.5%. Its 20-day historical volatility was 56.9%.
Data as of October 26, 2026.